Latest news
ResMed Inc Balances Astral Hit With Robust Core Growth - TipRanksTipRanks · Sun, 09 Aug 2026 01:08:08 GMTKeyBanc Maintains ResMed(RMD.US) With Buy Rating - MoomooMoomoo · Fri, 07 Aug 2026 11:12:45 GMTResmed Reports Strong Q4 Results and Dividend Increase - TipRanksTipRanks · Fri, 07 Aug 2026 03:17:34 GMTResMed reports Q4 EPS $2.95, consensus $2.89 - TipRanksTipRanks · Thu, 06 Aug 2026 23:52:54 GMTiRhythm: Strong Q2 Beat, Upgraded Outlook and VitalConnect Acquisition Underscore Buy Rating - TipRanksTipRanks · Thu, 06 Aug 2026 07:00:00 GMTMedline: Buy Rating Reaffirmed as Strong Q2 Results and Raised Organic Growth Guidance Offset Tariff and Margin Headwinds - TipRanksTipRanks · Wed, 05 Aug 2026 18:36:30 GMTResMed Updates July CDI Balances Amid Dual-Listing Share Movements - TipRanksTipRanks · Wed, 05 Aug 2026 07:17:54 GMTResmed (RME) Q3 2026 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Tue, 04 Aug 2026 20:13:45 GMT